Clinical Trial Update: Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

View source ↗

Summary

A completed clinical trial from the University of Pittsburgh examining risk factors for resistance to piperacillin/tazobactam among ESBL-producing Enterobacteri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterobacteriaceae Infections

Drugs mentioned

• Zosyn (piperacillin/tazobactam) (piperacillin/tazobactam)

Snippet

Sponsor: University of Pittsburgh | Conditions: Enterobacteriaceae Infections | Status: COMPLETED